scarletred
  • Home
  • Company
  • Products
    Scarletred®Vision
    Scarletred®Telemedicine
  • Services
  • Applications
  • CAREER
  • News
  • Contact
Menu
01
Home
02
Company
03
Products
04
Services
05
Applications
06
News
07
Contact
Get in touch
Austria
SCARLETRED Holding GmbH
MQM 3.4, Maria Jacobi Gasse 1,
8th floor, 1030 Vienna, Austria
USA
SCARLETRED Inc.
1 Broadway, 14th floor,
Cambridge, MA 02142, USA
office@scarletred.com
Privacy Policy
Social
Linkedin
Linkedin
Linkedin
Twitter
Instagram
Instagram
Facebook
Facebook
info
Press
Career
FAQ
Regulatory
Imprint

AAD 2023

Keywords:
#
DDDS Berlin
#
AAD 2025
#
Android
#
AAD 2024
#
Tissue Classifier
#
Conferences
#
Skin Care
AAD meeting in New Orleans, Louisiana, USA
News
•
Feb 20, 2023

SCARLETRED Joins 2023 AAD Annual Meeting in New Orleans, LA, USA

Our CEO Harald Schnidar is invited to present the results of a cooperation with GALDERMA and the University of Tübingen, wherein Scarletred®Vision confirmed the therapeutic efficacy of Ivermectin in Rosacea patients.
No items found.
Publication
•
November 29, 2024

AI powered Detection and Assessment of Onychomycosis: A Spotlight on Yellow and Deep Learning

Read more
Find us
  • SCARLETRED Holding GmbH 
    MQM 3.4, Maria Jacobi Gasse 1, 8th floor, 1030 Vienna, Austria
    ‍
    SCARLETRED Inc.
    1 Broadway, 14th floor,
    Cambridge, MA 02142, USA
About us
  • Company
  • Products
  • Services
  • Applications
  • News
Contact us
  • Press
  • Career
  • FAQ
  • Regulatory
  • Contact
linkedin-iconinstagram-iconfacebook-icon
Request a demo
Sign in
© 2024 SCARLETRED Holding GmbH
Home
Contact
Imprint
Terms and Conditions